UnitedHealth Group Inc. has reported its latest 10-K with a focus on its financial condition and results of operations for the year ended December 31, 2025. The company operates through two distinct but complementary businesses – Optum and UnitedHealthcare.
In 2026, the company realigned certain businesses, with Optum Financial, including Optum Bank, being included in Optum Insight. This realignment is a response to changes in the markets served and emerging opportunities as the health system evolves.
The company recorded a net gain of $568 million from various actions taken in the fourth quarter of 2025, including losses on business exits and dispositions, as well as a gain on the deconsolidation of a business. Additionally, restructuring and other actions in the same period resulted in a total impact of $2.5 billion, including real estate rationalization, workforce reductions, contractual reassessments, and net valuation losses on equity securities.
To support care providers impacted by a cyberattack, the company increased reserves for net collection expectations associated with provider loans and other customer balances by $799 million in the fourth quarter of 2025.
In terms of business trends, UnitedHealth Group primarily operates in the U.S. healthcare markets, where healthcare spending accounted for 19% of GDP in 2025. The company expects overall spending on healthcare to continue growing due to various factors, including inflation, medical technology advancements, and regulatory requirements.
The company faced challenges with pricing trends, as its pricing assumptions for 2025 were short of the medical cost trends incurred, significantly impacting earnings. It expects continued competition in the commercial risk market and anticipates a contraction in Medicare Advantage membership in 2026 due to funding pressures.
Medical cost trends have also been a concern, with increased care patterns and unit costs impacting the company's financials. The Inflation Reduction Act altered the Medicare Part D model and benefits, resulting in increased premiums and medical costs.
Despite these challenges, the company reported consolidated revenues of $447.6 billion for 2025, representing a 12% growth compared to the previous year. UnitedHealthcare revenues grew by 16%, and Optum revenues grew by 7%. However, earnings from operations were impacted, totaling $19.0 billion compared to $32.3 billion in the previous year, largely due to elevated medical cost trends and restructuring actions.
Diluted earnings per common share were reported at $13.23, and cash flows from operations amounted to $19.7 billion for the year.
The market has reacted to these announcements by moving the company's shares -2.34% to a price of $331.02. For the full picture, make sure to review UNITEDHEALTH GROUP INC's 10-K report.
